-
Biopharmas to disclose payments to nurses under bipartisan opioid bill
fiercepharma
September 28, 2018
Drug and medical device manufacturers have been reporting financial relationships with physicians to the U.S. government for years under the Physician Payments Sunshine Act.
-
Highest Opioid-Related Mortality Seen in Construction Jobs
drugs
September 13, 2018
Proportional mortality ratios (PMRs) for heroin-related overdose deaths and methadone-related overdose deaths from 2007 to 2012 were highest among construction workers, according to research published in the Aug.
-
Endo breaks from the pack with opioid litigation settlement talks
fiercepharma
September 12, 2018
Endo Pharmaceuticals has been settling litigation for hundreds of millions of dollars while it works to cut its $8 billion in debt.
-
Pharmaceutical opioids lead to more overdose deaths in Australia
pharmaceutical
August 22, 2018
A new report by University of New South Wales (UNSW Sydney) National Drug and Alcohol Research Centre has revealed that pharmaceutical opioids are major cause for associated overdose deaths.
-
Letters to doctors reduce opioid prescriptions, study shows
pharmafile
August 13, 2018
A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s fatal overdoses, prescribed fewer opioids.
-
CDC: Rates of Opioid Use Disorder Seen at Time of Delivery Up
drugs
August 13, 2018
Opioid use disorder rates at delivery more than quadrupled nationally from 1999 to 2014, according to research published in the Aug. 10 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
-
Number of Opioid-Addicted Women Giving Birth Quadruples
drugs
August 10, 2018
The number of pregnant women addicted to opioids as they give birth has more than quadrupled since 1999, a disturbing new report shows.
-
FDA Encourages Development of Treatments for Opioid Use Disorder
americanpharmaceuticalreview
August 07, 2018
The U.S. Food and Drug Administration (FDA) has issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT) drugs for the treatment of opioid use disorder (OUD).
-
Allergan sues Pfizer over opioid crisis lawsuits
pharmafile
August 06, 2018
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds of lawsuits that have been filed against them over their alleged role in the opioid crisis.
-
Opioid analgesics, Z-drugs linked to harmful effects in dementia patients
pharmatimes
July 26, 2018
Medicines commonly prescribed to dementia patients have been linked to an increase in harmful side-effects, according to new research involving the University of Exeter and King’s College London.